TRAIL induces apoptosis in various types of malignant tumor cells through its interaction with the death domain–containing receptors, TRAIL-R1 (DR4) and TRAIL-2 (DR5) with no effect on normal cells. This evidence concerns the gene TNFRSF10A and neoplasm.